Phillips Wealth Planners LLC Acquires New Stake in Sanofi (NASDAQ:SNY)

Phillips Wealth Planners LLC acquired a new stake in Sanofi (NASDAQ:SNY) during the 1st quarter, Holdings Channel.com reports. The firm acquired 9,550 shares of the company’s stock, valued at approximately $492,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Cardinal Capital Management increased its holdings in Sanofi by 0.3% during the 1st quarter. Cardinal Capital Management now owns 69,004 shares of the company’s stock worth $3,827,000 after purchasing an additional 199 shares during the period. Gradient Investments LLC grew its position in shares of Sanofi by 2.1% during the first quarter. Gradient Investments LLC now owns 9,764 shares of the company’s stock worth $542,000 after buying an additional 200 shares in the last quarter. Providence Capital Advisors LLC increased its stake in shares of Sanofi by 0.4% during the fourth quarter. Providence Capital Advisors LLC now owns 55,001 shares of the company’s stock worth $2,653,000 after buying an additional 201 shares during the period. Perigon Wealth Management LLC increased its stake in shares of Sanofi by 3.1% during the first quarter. Perigon Wealth Management LLC now owns 6,618 shares of the company’s stock worth $367,000 after buying an additional 201 shares during the period. Finally, Bailard Inc. increased its stake in shares of Sanofi by 1.4% during the fourth quarter. Bailard Inc. now owns 16,359 shares of the company’s stock worth $789,000 after buying an additional 220 shares during the period. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on SNY shares. Hsbc Global Res upgraded shares of Sanofi to a “strong-buy” rating in a research note on Monday, April 28th. BNP Paribas started coverage on shares of Sanofi in a research note on Tuesday, April 15th. They set an “outperform” rating and a $65.00 target price on the stock. The Goldman Sachs Group started coverage on shares of Sanofi in a research note on Friday, March 21st. They set a “neutral” rating and a $65.00 target price on the stock. Guggenheim restated a “buy” rating on shares of Sanofi in a research note on Tuesday, June 3rd. Finally, Morgan Stanley set a $56.00 target price on shares of Sanofi in a research note on Monday, June 2nd. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $61.50.

Sanofi Stock Performance

Shares of Sanofi stock opened at $47.80 on Thursday. The firm has a market capitalization of $117.23 billion, a P/E ratio of 17.07, a P/E/G ratio of 1.00 and a beta of 0.50. Sanofi has a 52 week low of $45.80 and a 52 week high of $60.12. The company has a quick ratio of 0.69, a current ratio of 1.37 and a debt-to-equity ratio of 0.16. The firm’s 50 day moving average is $51.06 and its two-hundred day moving average is $52.00.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings results on Thursday, April 24th. The company reported $0.94 EPS for the quarter, beating the consensus estimate of $0.90 by $0.04. The company had revenue of $10.41 billion for the quarter, compared to analyst estimates of $9.79 billion. Sanofi had a net margin of 14.56% and a return on equity of 17.15%. The firm’s revenue was down 11.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.78 earnings per share. Research analysts forecast that Sanofi will post 4.36 EPS for the current fiscal year.

Sanofi Increases Dividend

The business also recently declared an annual dividend, which was paid on Thursday, June 12th. Shareholders of record on Friday, May 9th were paid a $2.0369 dividend. This is a positive change from Sanofi’s previous annual dividend of $1.48. This represents a yield of 3.1%. The ex-dividend date was Friday, May 9th. Sanofi’s dividend payout ratio is currently 57.14%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.